Thor: Ragnarok’s Idris Elba Currently In talks To Take Over As Suicide Squad 2’s Deadshot

Author Thumbnail
By Tiny Diapana | More Articles
March 06, 2019  09:44 PM

 

 

Last month, word came out that Warner Brothers was planning to replace Will Smith after his decision to depart from Suicide Squad 2. Sure, Smith’s Deadshot might have been pretty well-received in the original Suicide Squad movie by David Ayer, but the actor’s limited schedule now serves as a hurdle to his appearance in the film’s sequel.

Now, it looks like Thor: Ragnarok star Idris Elba is set to make his way into the DC Extended Universe as Smith’s replacement. According to a new post by The Hollywood Reporter, Elba is currently in talks with Warner Brothers to take Smith’s place as Floyd Lawton, a character many know as the DC villain Deadshot.

Elba met with Suicide Squad 2 writer and director (rumored) James Gunn last Friday. Word on the street says that he’s the filmmaker and the studio’s “first and only choice” for the currently empty role. Of course, these negotiations could break down any time, however, the publication’s report indicates that Elba is most likely going to take on Smith’s role as Deadshot in Suicide Squad 2.

Elba heading over to the DCEU doesn’t sound improbable. After all, Elba’s role in the Marvel Cinematic Universe came to an end with Heimdall’s death in the opening sequence of Avengers: Infinity War. The actor has every opportunity to head on to another superhero franchise.

If he does take on the role, Elba will be joining Margot Robbie, the actress who plays the DCEU’s Harley Quinn.

Right now, Suicide Squad 2 has yet to receive a release date. But we’ll update everyone as soon as we get word.

Read: James Wan Confirms That 'Aquaman' Won't Have a Director's Cut

*Epic Stream may receive a small commission if you click a link from one of our articles onto a retail website and make a purchase. As an Amazon Associate, we earn from qualifying purchases. For more information, see our Cookie Policy. All prices listed were accurate at the time of publishing.